Pharmaceutical for oral delivery comprising MGBG and methods of treating disease
US9616035B2 · kind B2 · utility
0Cited by
17References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2013 |
| Grant date | Apr 11, 2017 |
| Priority date | — |
| Expiry date | Oct 25, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are new oral pharmaceutical compositions of MGBG and related polyamine analogs, polyamine biosynthesis inhibitors, polyamine inhibitors of AMD-I and regulators of osteopontin, and their application for the treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.